Biotechnology - Licensing, Emergent BioSolutions


Popular Filters

Valneva deal with Emergent BioSolutions for development of vaccines in the EB66 cell line


European biotechnology company Valneva has signed a new research license agreement and transferred an…

BiotechnologyEB66 cell lineEmergent BioSolutionsLicensingVaccinesValneva

Emergent BioSolutions gets exclusive US commercial rights to pandemic flu vaccine candidate


US vaccine maker Emergent BioSolutions (NYSE: EBS) has signed a license agreement with fellow USA-based…

BiotechnologyEmergent BioSolutionsLicensingNorth AmericaVaccinesVaxInnate Corp

Back to top